Pure Global AI
NCT04669353Completed

Platelet Rich Plasma and Wound Healing After Cesarean Section

The Effect of Autologous Application of Platelet Rich Plasma on Wound Healing and Pain Perception After Cesarean Section in a Low Resource Setting
Menoufia UniversityPhase 4ClinicalTrials.govdrug
Verified
Study focus
Disease/Condition
Infection
Drug/Device/Intervention
Platelet rich plasma
Study type
Interventional
Intervention type
drug
Sponsor & location
Primary sponsor
Menoufia University
Location
Cairo, Egypt
Timeline & enrollment
Phase
Phase 4
Start date
Apr 01, 2018
End date
Dec 30, 2020
Enrollment
200 participants
Primary outcome

Redness, Edema, Ecchymosis, Discharge, Approximation scale changes

Summary

Objective: To assess the effect of autologous Platelet Rich Plasma (PRP) on wound healing and
 pain perception in high risk women undergoing cesarean sections in a low resource setting.
 
 Methods: This was a randomized controlled trial of 200 women who attended the outpatient
 clinic of Menoufia University Hospital for elective cesarean surgery. The women were randomly
 assigned to two groups. The intervention group received PRP after surgery, whereas the
 control group received the usual care. Outcomes included Redness, Edema, Ecchymosis,
 Discharge, Approximation (REEDA) scale, Vancouver scar scale (VSS), and the visual analog
 scale (VAS).

ICD-10 classifications
Bacterial infection, unspecifiedBacterial, viral and other infectious agentsInfection following immunizationOther infectious diseasesViral infection, unspecified
Data source
Registry
ClinicalTrials.gov
Trial ID
NCT04669353
Type
Non-Device Trial
About this record

Access comprehensive clinical trial information for NCT04669353 through Pure Global AI's free database. This Phase 4 trial is sponsored by Menoufia University and is currently Completed. The study focuses on Infection. Target enrollment is 200 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.